1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 15 FEBRUARY 2016

CNS Drug News 15 FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Digital Healthcare Partnerships Offer Expedited Development Potential
Industry Brief - LCT Gains Ethics Approval For Ntcell Phase IIb Trial In PD
Industry Brief - Amarantus Receives FDA ODD For Eltoprazine In PD-LID
Industry Brief - Takeda/Zinfandel Complete Enrolment In Pioglitazone Phase III Trial In MCI Due To AD
Industry Brief - First Patient Dosed In Neurotrope's Phase IIb Trial Of Bryostatin In AD
Industry Trend Analysis - Generics Remain Essential For Teva As Copaxone Revenues Falter
Industry Trend Analysis - Expanded Label Will Increase Brintellix Commercial Viability
Industry Brief - Shionogi Submits S-877503 NDA For ADHD In Japan
Industry Brief - CHMP Adopts Positive Opinion On Abilify Maintena Label Update
Industry Brief - FDA Accepts Rexulti sNDA For Review In Maintenance Treatment Of Schizophrenia
Industry Brief - Alkermes Initiates Second Phase III Study Of ALKS 3831 In Schizophrenia
Industry Trend Analysis - Intuniv Sales Focus Will Remain On Non-US Markets
Industry Trend Analysis - Invalid Patent Ruling Will Allow Abuse Deterrence Alternatives
Industry Brief - Teligent Gains Lidocaine Approval
Industry Brief - Collegium Granted US Patent Covering DETERx Technology Platform
Industry Brief - Depomed Gains Favourable Markman Ruling In Tapentadol Litigation
Industry Brief - Eisai/Esteve Sign Fycompa Co-Promotion Deal In Spain
Industry Trend Analysis - 2016 Will Be Pivotal For GW Pharmaceuticals
Industry Trend Analysis - Expanded Injectable Approval Will Not Maintain Emend's Market Position
Industry Brief - Neurocrine Initiates Phase II Study of VMAT2 Inhibitor Valbenazine
Industry Brief - Asterias' AST-OPC1 Gains FDA ODD For Acute SCI
Industry Trend Analysis - Controversial Opioid Induced Constipation Ad Will Drive Opioid Debate
Industry Brief - Pozen/Tribute Merger Completed
Industry Trend Analysis - External Sourcing Remains UCB's Focus For CNS Pipeline
Industry Brief - Yumanity Therapeutics Completes Fundraising
Industry Trend Analysis - Strong FY15 Growth Will Support Shire's Shifting Focus
Industry Brief - CNS Conferences - May 2016

Table Of Contents

CNS Drug News 15 FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

Substance Abuse Treatment Market: By Addiction Substances (Alcohol, Drugs, Cigarettes and Coffee); By Category (Alcohol, Nicotine Dependence Therapeutics, Drug Abuse Therapeutics) & By Region -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Alcoholism and drug dependence and addiction, known as substance use disorders and rehabilitation treatments are classified as substance abuse treatment. Some of the common symptoms of drug abuse are ...

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

Psychotherapeutic Drugs Market: By Type (Antipsychotics, Antidepressants, Antimaniacs, and Anxiety Drugs) & By Geography -Forecast (2016-2021)

  • $ 5250
  • Industry report
  • August 2016
  • by Industry ARC

Psychotherapeutic drugs are used to treat mental illnesses such as extreme mood swings, social withdrawal, long lasting depression, confused thinking, and suicidal thought. schizophrenia, bipolar disorder, ...

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

Epiomic Epidemiology Series: Traumatic Brain Injury Forecast in 21 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • October 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Traumatic Brain Injury in 21 Major Markets Traumatic brain injury (TBI) or acquired brain injury is a non-specific term describing ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.